PETROS PHARMACEUTICALS INC (PTPI) Stock News

USA - NASDAQ:PTPI - US71678J2096 - Common Stock

0.0664 USD

-0.06 (-46.45%)

Last: 5/21/2025, 8:00:01 PM

0.0356 USD

-0.03 (-46.39%)

After Hours: 5/21/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

PTPI Latest News, Press Relases and Analysis

All

Press Releases

5 months ago - By: ACCESS Newswire

Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Company's Equity Position

6 months ago - By: Benzinga - Mentions: CVM BCLI IMMP LIPO ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

6 months ago - By: Benzinga - Mentions: HCTI JAGX ABVC APVO ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

6 months ago - By: ACCESS Newswire

Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets

6 months ago - By: ACCESS Newswire

Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer

6 months ago - By: ACCESS Newswire

Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms

6 months ago - By: ACCESS Newswire

Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform

6 months ago - By: ACCESS Newswire

Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches

6 months ago - By: Stocktwits

Petros Pharma Stock Plunges To Record Low On 1-For-25 Reverse Split, But Retail Optimism Lingers